Clinical Trials Directory

Trials / Completed

CompletedNCT04360993

Role of PET/MRI in Head and Neck Cancer

PET/CT and PET/MRI Based Treatment Modalities in the Modern Oncology

Status
Completed
Phase
Study type
Observational
Enrollment
110 (actual)
Sponsor
University of Pecs · Academic / Other
Sex
All
Age
41 Years – 88 Years
Healthy volunteers
Accepted

Summary

Study aim was to investigate the diagnostic role of Positron Emission Tomography / Magnetic Resonance Imaging (PET/MRI) in head and neck cancer.

Detailed description

This study was assessed the role of Diffusion weighted imaging (DWI) in discriminating between benign and malignant lesions in Head and neck cancer as well as studying the relationship between glucose metabolism (18F-FDG) and Apparent diffusion coefficient (ADC) for better tumor assessment.

Conditions

Interventions

TypeNameDescription
RADIATIONRadiotherapyPatients have received radiotherapy as a treatment modality for Head and neck cancer

Timeline

Start date
2016-04-12
Primary completion
2019-08-09
Completion
2020-01-22
First posted
2020-04-24
Last updated
2020-12-29

Source: ClinicalTrials.gov record NCT04360993. Inclusion in this directory is not an endorsement.